The 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases.
Can Weight Loss From GLP-1s or Double/Triple Agonists Emulate the Effects of Bariatric Surgery in SPLENDOR?
In Season 3, Episode 46, program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Roger Green on-site from Dublin to review their reactions immediately after the conference ended. The panelists note the impact of weight change and lifestyle modification in clinical trials while utilizing insights from the bariatric and diabetes fields.
In this episode From the Vault, Roger Green, Stephen Harrison, Ali Aminian and Wayne Eskridge discuss how weight loss and GLP-1s or Double/Triple Agonists in relation to SPLENDOR. This conversation comes from Season 2, Episode 61.3.
Season 3, Episode 46 is sponsored by Resoundant, a Mayo Clinic company and the developers of Magnetic Resonance Elastography. MRE is widely available with over 2000 locations worldwide, and can be done as a low-cost, rapid exam in just 5 minutes. Together with PDFF, this quantitative exam is called an Hepatogram – a powerful non-invasive alternative to liver biopsy in many cases. For more information, visit www.resoundant.com on the web.
